Literature DB >> 2314525

Erythropoietin and anemia in the progression of Balkan endemic nephropathy and other renal diseases.

V Pavlović-Kentera1, G K Clemons, S Trbojević, N Dimković, L Djukanović.   

Abstract

We have investigated anemia in patients at different stages of the evolution of three chronic renal diseases: Balkan endemic nephropathy (BEN), chronic pyelonephritis (PN) and chronic glomerulonephritis (GN). A total of 88 patients with creatinine clearances from 9 to 118 ml/min and hemoglobin concentrations from 70 to 160 g/l were studied with regard to the relationship, if any, between erythropoietin production and the type and stage of nephropathy. Anemia in BEN was a particular focus of interest since it had been stated that in BEN, anemia precedes renal failure. Our data neither prove nor disprove this statement. A significant positive correlation between creatinine clearance and hemoglobin concentration was found in all three nephropathies, indicating that in the patients studied the severity of anemia increased with the impairment of renal function regardless of the underlying disease. Serum levels of immunoreactive erythropoietin were in the normal range in 54 patients, moderately increased in 20 and slightly decreased in 14. The erythropoietin level appears to be unrelated to the stage of renal failure or the type of nephropathy. The only exception was the subgroup where the patients with glomerulonephritis and normal renal function had increased serum erythropoietin levels and significantly higher parameters of red blood cell concentration than the patients from the same subgroup with tubulointerstitial nephropathies. In patients with severe renal failure and anemia, serum erythropoietin levels were inappropriately low for the degree of anemia, indicating that erythropoietin plays a role in the pathogenesis of the anemia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2314525     DOI: 10.1159/000185834

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  3 in total

1.  Erythropoietin inhibits SGK1-dependent TH17 induction and TH17-dependent kidney disease.

Authors:  Chiara Donadei; Andrea Angeletti; Chiara Cantarelli; Vivette D D'Agati; Gaetano La Manna; Enrico Fiaccadori; Julian K Horwitz; Huabao Xiong; Chiara Guglielmo; Susan Hartzell; Joren C Madsen; Umberto Maggiore; Peter S Heeger; Paolo Cravedi
Journal:  JCI Insight       Date:  2019-04-23

2.  Renal clearance of endogenous erythropoietin in patients with proteinuria.

Authors:  M Nowicki; F Kokot; M Kokot; A Bar; J Duława
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

Review 3.  Balkan nephropathy: evolution of our knowledge.

Authors:  Giorgos Bamias; John Boletis
Journal:  Am J Kidney Dis       Date:  2008-09       Impact factor: 8.860

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.